Study for Using Radiosurgery on Limited Metastases of Breast Cancer

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2000-12-31

Study Completion Date

2016-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether radiosurgery, along with standard chemotherapy, immunotherapy (the treatment of cancer by modulating the immune system and immune response), or hormonal therapy, affects the quality and length of life. The standard therapy is surgery, radiation therapy, or chemotherapy alone or in any combination. A second purpose of this study is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to the quality of life while on this treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients

NCT02441270

Radiotherapy Immunology

WITHDRAWN EARLY_PHASE1

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

NCT06129747

Breast Cancer Tumor, Breast

RECRUITING PHASE2

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

NCT03457467

Breast Cancer

UNKNOWN PHASE2

Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC

NCT03051672

Metastatic Breast Cancer

TERMINATED PHASE2

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

NCT03691493

Anatomic Stage IV Breast Cancer AJCC v8 Estrogen Receptor Positive HER2/Neu Negative +4 more

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Before treatment begins, you will have a physical exam and blood tests. Physical evaluations and blood tests will be done each week while you are receiving treatment, and at follow-up visits. You will be seen for follow-up evaluations 4 weeks after treatment is completed, and every three months thereafter. You will be asked to fill out a Quality of Life questionnaire, which should take 5-10 minutes to complete. This will be done prior to treatment and at your follow-up visits. You will receive high dose radiation therapy directed at the site of metastasis. This treatment will be given once a day, 5 times a week (Monday through Friday) for one to four weeks depending on the location and size of the disease to be treated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer, Metastatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypofractionated Stereotactic Body Radiation Therapy

Use of Hypofractionated Stereotactic Body Radiation Therapy for limited metastases with breast cancer primary.

Group Type EXPERIMENTAL

Hypofractionated Stereotactic Body Radiation Therapy

Intervention Type PROCEDURE

Hypofractionated Stereotactic Body Radiation Therapy

Intervention Type RADIATION

Hypofractionated Stereotactic Body Radiation Therapy for treatment of limited metastases from breast cancer primary.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypofractionated Stereotactic Body Radiation Therapy

Intervention Type PROCEDURE

Hypofractionated Stereotactic Body Radiation Therapy

Hypofractionated Stereotactic Body Radiation Therapy for treatment of limited metastases from breast cancer primary.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: no limit
* Karnofsky performance status (KPS) ≥ 70
* No more than 5 metastatic sites involving one or more different organs (liver, lung or bone).
* The size of the lesion must be such that it can be safely treated to sterilizing radiation doses according to the rules in the protocol.
* Previously treated lesions are not eligible unless the prescribed dose can be safely delivered.
* Concurrent therapy is allowed and recommended. The chemotherapy protocol type and schedule are at the discretion of the medical oncologist.
* Informed consent must be obtained.
* Pregnancy test must be negative for women of child bearing potential

* Contraindications to radiation.

Exclusion Criteria

* Inability of patient to be followed longitudinally as specified by protocol.
* Technical inability to achieve required dose based on safe dose constraints required for radiosurgery.
* Women who are pregnant or nursing.

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No